About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Agl
amylo-1,6-glucosidase, 4-alpha-glucanotransferase
MGI:1924809
40 phenotypes from 3 alleles in 3 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
involves: C57BL/6N 		abnormal hepatocyte morphology J:212003
decreased grip strength J:212003
decreased locomotor activity J:212003
enlarged liver J:212003
hypoglycemia J:212003
increased cardiac muscle glycogen level J:212003
increased circulating alanine transaminase level J:212003
increased circulating alkaline phosphatase level J:212003
increased circulating aspartate transaminase level J:212003
increased circulating creatine kinase level J:212003
increased liver glycogen level J:212003
increased skeletal muscle glycogen level J:212003
liver fibrosis J:212003
muscle weakness J:212003
premature death J:212003
Agltm1b(EUCOMM)Wtsi/Agl+
C57BL/6N-Agltm1b(EUCOMM)Wtsi/H 		tremors J:211773
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
C57BL/6N-Agltm1b(EUCOMM)Wtsi/H 		abnormal gait J:211773
cataract J:211773
decreased bone mineral content J:211773
decreased bone mineral density J:211773
decreased circulating glucose level J:211773
decreased total body fat amount J:211773
impaired glucose tolerance J:211773
increased circulating alanine transaminase level J:211773
increased circulating alkaline phosphatase level J:211773
increased circulating amylase level J:211773
increased circulating aspartate transaminase level J:211773
increased circulating bilirubin level J:211773
increased circulating cholesterol level J:211773
increased circulating creatine kinase level J:211773
increased circulating iron level J:211773
increased fasting circulating glucose level J:211773
increased heart weight J:211773
increased kidney weight J:211773
increased lean body mass J:211773
preweaning lethality, incomplete penetrance J:211773
Agltm1Geno/Agltm1Geno
C57BL/6J-Agltm1Geno 		abnormal gait J:218471
abnormal hepatocyte morphology J:218471
abnormal liver morphology J:218471
decreased circulating glucose level J:218471
decreased fasting circulating glucose level J:218471
enlarged liver J:218471
impaired coordination J:218471
impaired exercise endurance J:218471
increased brain glycogen level J:218471
increased cardiac muscle glycogen level J:218471
increased circulating alanine transaminase level J:218471
increased circulating alkaline phosphatase level J:218471
increased circulating aspartate transaminase level J:218471
increased circulating creatine kinase level J:218471
increased glycogen level J:218471
increased liver glycogen level J:218471
increased pulmonary respiratory rate J:218471
increased skeletal muscle glycogen level J:218471
kyphosis J:218471
premature death J:218471
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory